These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34127731)

  • 1. Immune modulation via adipose derived Mesenchymal Stem cells is driven by donor sex in vitro.
    Mckinnirey F; Herbert B; Vesey G; McCracken S
    Sci Rep; 2021 Jun; 11(1):12454. PubMed ID: 34127731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
    Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
    J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of human mesenchymal stromal cells with peripheral blood mononuclear cells in a Mitogenic proliferation assay.
    Herzig MC; Christy BA; Montgomery RK; Delavan CP; Jensen KJ; Lovelace SE; Cantu C; Salgado CL; Cap AP; Bynum JA
    J Immunol Methods; 2021 May; 492():113000. PubMed ID: 33609532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.
    Melief SM; Zwaginga JJ; Fibbe WE; Roelofs H
    Stem Cells Transl Med; 2013 Jun; 2(6):455-63. PubMed ID: 23694810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire.
    Davies LC; Queckbörner S; Jylhä CE; Andrén AT; Forshell TZP; Blanc KL
    Cytotherapy; 2023 Sep; 25(9):956-966. PubMed ID: 37354149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic and proteomic profiles of fetal versus adult mesenchymal stromal cells and mesenchymal stromal cell-derived extracellular vesicles.
    Gençer EB; Lor YK; Abomaray F; El Andaloussi S; Pernemalm M; Sharma N; Hagey DW; Görgens A; Gustafsson MO; Le Blanc K; Asad Toonsi M; Walther-Jallow L; Götherström C
    Stem Cell Res Ther; 2024 Mar; 15(1):77. PubMed ID: 38475970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
    Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
    Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.
    Redondo-Castro E; Cunningham CJ; Miller J; Brown H; Allan SM; Pinteaux E
    Stem Cell Res Ther; 2018 Jan; 9(1):11. PubMed ID: 29343288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory factors produced by adipose mesenchymal stem cells downregulate Th17 and increase Treg cells in peripheral blood mononuclear cells from rheumatoid arthritis patients.
    Vasilev G; Ivanova M; Ivanova-Todorova E; Tumangelova-Yuzeir K; Krasimirova E; Stoilov R; Kyurkchiev D
    Rheumatol Int; 2019 May; 39(5):819-826. PubMed ID: 30944956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes.
    Herzig MC; Christy BA; Montgomery RK; Cantu-Garza C; Barrera GD; Lee JH; Mucha N; Talackine JR; Abaasah IA; Bynum JA; Cap AP
    Front Immunol; 2023; 14():1225047. PubMed ID: 37822938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of type 2 diabetes mellitus on the immunoregulatory characteristics of adipose tissue-derived mesenchymal stem cells.
    Abu-Shahba N; Mahmoud M; El-Erian AM; Husseiny MI; Nour-Eldeen G; Helwa I; Amr K; ElHefnawi M; Othman AI; Ibrahim SA; Azmy O
    Int J Biochem Cell Biol; 2021 Nov; 140():106072. PubMed ID: 34455058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells.
    Siegel G; Kluba T; Hermanutz-Klein U; Bieback K; Northoff H; Schäfer R
    BMC Med; 2013 Jun; 11():146. PubMed ID: 23758701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Immune Suppression Utilized by Canine Adipose and Bone Marrow-Derived Mesenchymal Stem Cells.
    Chow L; Johnson V; Coy J; Regan D; Dow S
    Stem Cells Dev; 2017 Mar; 26(5):374-389. PubMed ID: 27881051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients.
    Ma L; Zhou Z; Zhang D; Yang S; Wang J; Xue F; Yang Y; Yang R
    Thromb Haemost; 2012 May; 107(5):937-50. PubMed ID: 22398715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of soluble factors secreted by feline adipose tissue-derived mesenchymal stem cells.
    Chae HK; Song WJ; Ahn JO; Li Q; Lee BY; Kweon K; Park SC; Youn HY
    Vet Immunol Immunopathol; 2017 Sep; 191():22-29. PubMed ID: 28895862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2.
    Zhang Z; Huang S; Wu S; Qi J; Li W; Liu S; Cong Y; Chen H; Lu L; Shi S; Wang D; Chen W; Sun L
    EBioMedicine; 2019 Jul; 45():341-350. PubMed ID: 31248835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells do not suppress lymphoblastic leukemic cell line proliferation.
    Mousavi Niri N; Jaberipour M; Razmkhah M; Ghaderi A; Habibagahi M
    Iran J Immunol; 2009 Dec; 6(4):186-94. PubMed ID: 20054106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stromal cells from infants with simple polydactyly modulate immune responses more efficiently than adult mesenchymal stromal cells.
    Myneni VD; McClain-Caldwell I; Martin D; Vitale-Cross L; Marko K; Firriolo JM; Labow BI; Mezey E
    Cytotherapy; 2019 Feb; 21(2):148-161. PubMed ID: 30595353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.